ProfileGDS4132 / 230408_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 38% 47% 38% 34% 36% 45% 36% 45% 40% 33% 20% 32% 35% 33% 29% 27% 32% 47% 34% 27% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10198.268438
GSM201543Muscle PCOS pioglitazone 121116.33747
GSM201544Muscle PCOS pioglitazone 16199.665138
GSM201545Muscle PCOS pioglitazone 20192.8234
GSM201829Muscle PCOS pioglitazone 23197.704136
GSM201830Muscle PCOS pioglitazon 251122.79745
GSM201831Muscle PCOS pioglitazone 27190.164536
GSM201832Muscle PCOS pioglitazone 31116.28845
GSM201833Muscle PCOS pioglitazone 4196.316740
GSM201834Muscle PCOS pioglitazone 8179.608333
GSM201835Muscle PCOS after pioglitazone 10232.657320
GSM201836Muscle PCOS after pioglitazone 12268.068632
GSM201837Muscle PCOS after pioglitazone 16275.254735
GSM201838Muscle PCOS after pioglitazone 20272.670533
GSM201839Muscle PCOS after pioglitazone 23265.024429
GSM201840Muscle PCOS after pioglitazone 25261.351627
GSM201841Muscle PCOS after pioglitazone 27266.571132
GSM201842Muscle PCOS after pioglitazone 32102.20147
GSM201843Muscle PCOS after pioglitazone 4282.6234
GSM201844Muscle PCOS after pioglitazone 8260.700527